The same week that 100,000 doses of Chinese-made COVID-19 vaccines arrived in Africa for the first time, news emerged from the World Health Organization that its Covax vaccine alliance is in trouble.
Reuters reported that a lack of funds, supply risks, and complex contractual arrangements are all endangering Covax’s plan to provide vaccines to up to 20% of a country’s population, prompting growing concern that people in poor and middle-income countries will have to wait for two, three, possibly four years longer than residents in wealthier countries.
- Get a daily email packed with the latest China-Africa news and analysis.
- Read exclusive insights on the key trends shaping China-Africa relations.
- Full access to the News Feed that provides daily updates on Chinese engagement in Africa and throughout the Global South.